Núria Segarra

857 total citations
27 papers, 656 citations indexed

About

Núria Segarra is a scholar working on Psychiatry and Mental health, Cognitive Neuroscience and Oncology. According to data from OpenAlex, Núria Segarra has authored 27 papers receiving a total of 656 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Psychiatry and Mental health, 8 papers in Cognitive Neuroscience and 6 papers in Oncology. Recurrent topics in Núria Segarra's work include Schizophrenia research and treatment (13 papers), Functional Brain Connectivity Studies (6 papers) and Cancer Immunotherapy and Biomarkers (4 papers). Núria Segarra is often cited by papers focused on Schizophrenia research and treatment (13 papers), Functional Brain Connectivity Studies (6 papers) and Cancer Immunotherapy and Biomarkers (4 papers). Núria Segarra collaborates with scholars based in Spain, United Kingdom and United States. Núria Segarra's co-authors include Miquel Bernardo, Robert B. Dudas, Paul C. Fletcher, Antonio Metastasio, Hisham Ziauddeen, Graham K. Murray, Trevor W. Robbins, Niels R. Reinders, Gonzalo Arrondo and Anabel Martínez‐Arán and has published in prestigious journals such as The British Journal of Psychiatry, Annals of Oncology and Psychological Medicine.

In The Last Decade

Núria Segarra

27 papers receiving 644 citations

Peers

Countries citing papers authored by Núria Segarra

Since Specialization

Citations

This map shows the geographic impact of Núria Segarra's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Núria Segarra with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Núria Segarra more than expected).

Fields of papers citing papers by Núria Segarra

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Núria Segarra. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Núria Segarra. The network helps show where Núria Segarra may publish in the future.

Co-authorship network of co-authors of Núria Segarra

This figure shows the co-authorship network connecting the top 25 collaborators of Núria Segarra. A scholar is included among the top collaborators of Núria Segarra based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Núria Segarra. Núria Segarra is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Clozapine-induced obsessive-compulsive symptoms in schizophrenia: Clinical and cognitive determinants of dysfunctional checking 2025 ·Psychological Medicine ·(unknown), Paula Banca, Isaac Jarratt Barnham, (unknown), Núria Segarra, (unknown), Akeem Sule, (unknown), Qiang Luo, Naomi Fineberg, Emilio Fernández-Egea, Trevor W. Robbins	1
2	The role of psychosis and clozapine load in excessive checking in treatment-resistant schizophrenia: longitudinal observational study 2024 ·The British Journal of Psychiatry ·Emilio Fernández-Egea, Shanquan Chen, (unknown), Patricia Gassó, (unknown), (unknown), Isaac Jarratt Barnham, Núria Segarra, Sergi Mas, (unknown), Cristina Belén García, Naomi Fineberg, Yulia Worbe, Rudolf N. Cardinal, Trevor W. Robbins	2
3	1440P Final top-line results of the BGBC008 phase II, multicenter study of bemcentinib and pembrolizumab (bem+pembro) in second-line (2L) advanced non-squamous (NS) non-small cell lung cancer (NSCLC) (NCT03184571) 2023 ·Annals of Oncology ·Enriqueta Felip, (unknown), Enric Carcereny, Knut B. Smeland, Edurne Arriola, (unknown), Jonathan R. Thompson, Luis Paz‐Ares, M. Dómine Gómez, (unknown), Núria Segarra, M.R. García-Campelo, Ana Laura Ortega Granados, Michael Chisamore, David Micklem, (unknown), (unknown), (unknown), (unknown), James Spicer	2
4	138P Prevalence and characteristics of lung cancer in families harboring pathogenic germline variants in cancer predisposing genes 2022 ·Annals of Oncology ·(unknown), (unknown), L. Moreno, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Roxana Reyes, Daniel Martı́nez, Núria Segarra, Lydia Gaba, Bárbara Adamo, (unknown), (unknown), Cristina Teixidó, Laura Mezquita	2
5	157MO Immune gene signatures for predicting pathological response of NSCLC patients treated with neoadjuvant chemoimmunotherapy 2022 ·Annals of Oncology ·Marta Casarrubios, Alberto Cruz‐Bermúdez, (unknown), Ernest Nadal, (unknown), (unknown), (unknown), M. Dómine Gómez, M. Majem Tarruella, Delvys Rodríguez‐Abreu, Alex Martínez‐Martí, (unknown), Manuel Cobo, Guillermo López-Vivanco, Núria Segarra, (unknown), Santiago Viteri, (unknown), Mariano Provencio	1
6	Clozapine-related obsessive–compulsive symptoms and their impact on wellbeing: a naturalistic longitudinal study 2022 ·Psychological Medicine ·(unknown), Shanquan Chen, (unknown), (unknown), Helen Beckwith, Isaac Jarratt Barnham, Núria Segarra, Yulia Worbe, Naomi Fineberg, Rudolf N. Cardinal, Trevor W. Robbins, Emilio Fernández-Egea	5
7	1420TiP A phase I/II trial of radium-223 (Ra-223) in combination with pembrolizumab in patients (pts) with stage IV non-small cell lung cancer (NSCLC) 2020 ·Annals of Oncology ·Martin Reck, Kathryn F. Mileham, D.A. Clump, Lore Decoster, Anna Estival, Enriqueta Felip, (unknown), Luis Paz‐Ares, Martin Sebastian, Núria Segarra, Veerle Surmont, (unknown), Salvatore Galdy, Egbert F. Smit	2
8	P2.04-27 Ph II Study of Oral Selective AXL Inhibitor Bemcentinib (BGB324) in Combination with Pembrolizumab in Patients with Advanced NSCLC 2018 ·Journal of Thoracic Oncology ·Carlos Arce‐Lara, Edurne Arriola, Paal Brunsvig, Enric Carcereny, Manuel Dómine, (unknown), Enriqueta Felip, Rosario García Campelo, Matthew Krebs, Luis Paz‐Ares, Santiago Ponce Aix, James Spicer, José Trigo, Núria Segarra, Robert A. Holt, David Micklem, (unknown), Michael Chisamore, James B. Lorens	1
9	Lung cancer diagnosis by trained dogs† 2017 ·European Journal of Cardio-Thoracic Surgery ·(unknown), (unknown), (unknown), (unknown), Núria Segarra, (unknown), Jorge Hernández, (unknown), (unknown)	16
10	A randomized, phase 2 evaluation of the CHK1 inhibitor, LY2603618, administered in combination with pemetrexed and cisplatin in patients with advanced nonsquamous non‐small cell lung cancer 2017 ·Lung Cancer ·Thomas Wehler, Michael Thomas, Christian Schumann, Joaquim Bosch‐Barrera, Núria Segarra, Nicolas Dickgreber, Klaus Dalhoff, Martin Sebastian, Jesus Corral Jaime, Miriam Alonso, Scott M. Hynes, Ji Lin, Karla Hurt, Aimee Bence Lin, Emiliano Calvo, Luis Paz‐Ares	39
11	Abnormal Frontostriatal Activity During Unexpected Reward Receipt in Depression and Schizophrenia: Relationship to Anhedonia 2015 ·Neuropsychopharmacology ·Núria Segarra, Antonio Metastasio, Hisham Ziauddeen, (unknown), Niels R. Reinders, Robert B. Dudas, Gonzalo Arrondo, Trevor W. Robbins, Luke Clark, Paul C. Fletcher, Graham K. Murray	74
12	Brain Structural Signatures of Negative Symptoms in Depression and Schizophrenia 2014 ·Frontiers in Psychiatry ·(unknown), Graham K. Murray, Antonio Metastasio, Núria Segarra, Roger Tait, (unknown), Hisham Ziauddeen, Robert B. Dudas, Paul C. Fletcher, John Suckling	28
13	Brief cognitive assessment instruments in schizophrenia and bipolar patients, and healthy control subjects: A comparison study between the Brief Cognitive Assessment Tool for Schizophrenia (B-CATS) and the Screen for Cognitive Impairment in Psychiatry (SCIP) 2011 ·Schizophrenia Research ·Manuel J. Cuesta, Óscar Pino, Georgina Guilera, Emilio Rojo, Juana Gómez‐Benito, Scot E. Purdon, Manuel Franco, Anabel Martínez‐Arán, Núria Segarra, Rafael Tabarés‐Seisdedos, Eduard Vieta, Miquel Bernardo, Benedicto Crespo‐Facorro, Francisco Mesa, Javier Rejas	42
14	Spanish Validation Of the Brief Assessment in Cognition in Schizophrenia (Bacs) in Patients With Schizophrenia and Healthy Controls 2010 ·European Psychiatry ·Núria Segarra, Miquel Bernardo, Fernando Gutiérrez, Azucena Justicia, (unknown), (unknown), Gemma Safont, Fernando Contreras, Joaquím Gascón, (unknown), José M. Menchón, Carme Junqué, Richard S.E. Keefe	64
15	Neurocognitive diagnosis and cut-off scores of the Screen for Cognitive Impairment in Psychiatry (SCIP-S) 2009 ·Schizophrenia Research ·Emilio Rojo, Óscar Pino, Georgina Guilera, Juana Gómez‐Benito, Scot E. Purdon, Benedicto Crespo‐Facorro, Manuel J. Cuesta, Manuel Franco, Anabel Martínez‐Arán, Núria Segarra, Rafael Tabarés‐Seisdedos, Eduard Vieta, Miquel Bernardo, Francisco Mesa, Javier Rejas	57
16	Cerebellar deficits in schizophrenia are associated with executive dysfuntion 2008 ·Neuroreport ·Núria Segarra, Miquel Bernardo, Carlos Manuel, Xavier Caldú, (unknown), Lorena Rami, Núria Bargalló, (unknown), Carme Junqué	32
17	Angiogenesis inhibitors in the treatment of non-small-cell lung cancer (NSCLC) 2008 ·Clinical & Translational Oncology ·Enric Carcereny, Núria Segarra, (unknown)	2
18	Spanish version of the Screen for Cognitive Impairment in Psychiatry (SCIP-S): Psychometric properties of a brief scale for cognitive evaluation in schizophrenia 2007 ·Schizophrenia Research ·Óscar Pino, Georgina Guilera, Emilio Rojo, Juana Gómez‐Benito, Miquel Bernardo, Benedicto Crespo‐Facorro, Manuel J. Cuesta, Manuel Franco, Anabel Martínez‐Arán, Núria Segarra, Rafael Tabarés‐Seisdedos, Eduard Vieta, Scot E. Purdon, Teresa Díez, Javier Rejas	82
19	Left posterior hippocampal density reduction using VBM and stereological MRI procedures in schizophrenia 2007 ·Schizophrenia Research ·Giuseppina Rametti, Núria Segarra, Carme Junqué, Núria Bargalló, Xavier Caldú, Naroa Ibarretxe‐Bilbao, Miquel Bernardo	33
20	El pont de barques en l'època moderna segons els llibres d'albarans 1993 ·Dialnet (Universidad de la Rioja) ·(unknown), Núria Segarra	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact